Grapefruit USA, Inc. (GPFT)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Grapefruit USA, Inc. (GPFT) with AI Score 45/100 (Weak). Grapefruit USA, Inc. is a manufacturer and distributor of cannabis products, primarily operating in California. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Grapefruit USA, Inc. (GPFT) Healthcare & Pipeline Overview
Grapefruit USA, Inc., established in 2017, operates within the specialty cannabis market, focusing on the manufacturing and distribution of THC and CBD-infused products. Its core offering, Hourglass cream, is sold online, positioning the company within the niche of topical cannabis treatments in California's competitive landscape.
Investment Thesis
Grapefruit USA, Inc. presents a high-risk, high-reward investment profile, given its position in the volatile cannabis market. The company's focus on a single product, Hourglass cream, creates both opportunity and vulnerability. Potential investors may want to evaluate the limited operational scale, with only 9 employees, and the negative P/E ratio of -0.90, reflecting current unprofitability. Growth hinges on expanding market reach within California and developing new products. The company's beta of -0.32 suggests a low correlation with the broader market, which may offer diversification benefits. However, the OTC listing and lack of dividend payments indicate a speculative investment.
Based on FMP financials and quantitative analysis
Key Highlights
- Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California.
- The company's primary product is Hourglass, a time-release THC+CBD-infused topical cream.
- The company sells its products directly to consumers through its online store.
- Grapefruit USA, Inc. has a market capitalization of $0.00B.
- The company's P/E ratio is -0.90, indicating current unprofitability.
Competitors & Peers
Strengths
- Focus on a specific niche (topical cannabis).
- Direct-to-consumer online sales.
- Proprietary product formulation (Hourglass).
- Established presence in the California market.
Weaknesses
- Limited product line (primarily Hourglass cream).
- Small operational scale (9 employees).
- Dependence on the California market.
- Negative P/E ratio indicating unprofitability.
Catalysts
- Upcoming: Potential legalization of recreational cannabis in additional states, expanding the market for Grapefruit USA's products.
- Ongoing: Increasing consumer acceptance of cannabis-infused topicals for pain relief and wellness.
- Upcoming: Development and launch of new cannabis-infused products beyond Hourglass cream.
- Ongoing: Expansion of online marketing and sales efforts to reach a wider customer base.
Risks
- Potential: Intense competition from established players in the cannabis industry.
- Ongoing: Changing regulations and legal landscape for cannabis products.
- Potential: Fluctuations in cannabis prices and demand impacting profitability.
- Ongoing: Limited financial resources and operational scale compared to larger competitors.
- Potential: Negative perception of cannabis products among some consumers.
Growth Opportunities
- Product Line Expansion: Grapefruit USA, Inc. can expand its product line beyond Hourglass cream to include other cannabis-infused topicals, edibles, and concentrates. The cannabis edibles market, for example, is projected to reach $5.8 billion by 2027, offering a significant growth avenue. Introducing new products can attract a broader customer base and increase revenue streams. This expansion should be carefully aligned with market demand and regulatory requirements.
- Geographic Expansion within California: While currently focused on online sales, Grapefruit USA, Inc. can explore partnerships with dispensaries and retailers across California to increase its market presence. California's cannabis market is one of the largest in the United States, providing ample opportunities for growth. Establishing a physical presence can enhance brand visibility and accessibility to consumers. The timeline for this expansion depends on securing partnerships and navigating local regulations.
- Strategic Partnerships: Grapefruit USA, Inc. can form strategic alliances with other companies in the cannabis industry, such as cultivators, processors, and distributors, to streamline its supply chain and reduce costs. Collaborations can also extend to research and development, enabling the company to innovate and develop new products. These partnerships can enhance Grapefruit USA's competitive advantage and accelerate its growth trajectory.
- Direct-to-Consumer Marketing: Grapefruit USA, Inc. can enhance its direct-to-consumer marketing efforts through targeted online advertising, social media campaigns, and email marketing. By focusing on specific customer segments and tailoring its messaging, the company can increase brand awareness and drive sales. Investing in digital marketing infrastructure and analytics can improve the effectiveness of these campaigns. The timeline for seeing results from these efforts is typically within a few months.
- Research and Development: Investing in research and development to create innovative cannabis-infused products can differentiate Grapefruit USA, Inc. from its competitors. Focusing on unique formulations, delivery methods, and therapeutic applications can attract customers seeking specialized solutions. Collaborating with research institutions and universities can provide access to cutting-edge technologies and expertise. The timeline for developing and commercializing new products can range from one to three years.
Opportunities
- Expansion of product line to include other cannabis products.
- Geographic expansion within California.
- Strategic partnerships with other cannabis companies.
- Increased direct-to-consumer marketing efforts.
Threats
- Intense competition in the cannabis industry.
- Changing regulations and legal landscape.
- Fluctuations in cannabis prices and demand.
- Potential for new entrants and disruptive technologies.
Competitive Advantages
- Focus on a niche market (topical cannabis solutions).
- Direct-to-consumer online sales channel.
- Proprietary formulation of Hourglass cream.
- Established brand presence in the California market.
About GPFT
Grapefruit USA, Inc., founded in 2017, is a cannabis company operating as a manufacturer and distributor of cannabis products in California. Originally named Grapefruit Boulevard Investments, Inc., the company rebranded to Grapefruit USA, Inc. in January 2020, marking a shift in its strategic focus. The company's primary product is Hourglass, a time-release THC+CBD-infused topical cream, which is sold directly to consumers through its online store. Based in Wilmington, Delaware, Grapefruit USA targets the specialty cannabis market with its unique topical application. The company's business model centers on developing and marketing cannabis-infused products that cater to specific consumer needs. While the company's operations are primarily based in California, its corporate structure is established in Delaware. Grapefruit USA aims to differentiate itself through its focus on topical cannabis solutions and direct-to-consumer sales, navigating the evolving regulatory landscape of the cannabis industry.
What They Do
- Manufactures cannabis products
- Distributes cannabis products in California
- Specializes in THC+CBD-infused products
- Offers Hourglass, a time-release topical cream
- Sells products through its online store
- Focuses on the specialty cannabis market
Business Model
- Develops and manufactures cannabis-infused topical creams.
- Sells products directly to consumers through an online platform.
- Focuses on the California cannabis market.
- Generates revenue through product sales.
Industry Context
Grapefruit USA, Inc. operates within the rapidly evolving cannabis industry, specifically targeting the specialty and generic drug manufacturing segment. The legal cannabis market is experiencing substantial growth, driven by increasing acceptance and legalization in various regions. However, the industry is also characterized by intense competition and regulatory complexities. Grapefruit USA's focus on topical cannabis products positions it within a niche market that may offer growth opportunities but also faces challenges from established players and changing consumer preferences. Competitors include companies like CBDL, FFNTF, HPMM, IVIXF, and JUVAF, each vying for market share in different segments of the cannabis industry.
Key Customers
- Consumers seeking cannabis-infused topical solutions.
- Individuals looking for time-release THC+CBD products.
- Customers in California interested in cannabis products.
- Online shoppers interested in cannabis-related items.
Financials
Chart & Info
Grapefruit USA, Inc. (GPFT) stock price: Price data unavailable
Latest News
No recent news available for GPFT.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GPFT.
Price Targets
Wall Street price target analysis for GPFT.
MoonshotScore
What does this score mean?
The MoonshotScore rates GPFT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Bradley J. Yourist
CEO
Bradley J. Yourist serves as the CEO of Grapefruit USA, Inc. His background and experience prior to joining Grapefruit USA are Unknown. As CEO, he is responsible for overseeing the company's strategic direction, operations, and financial performance. His leadership is critical in navigating the evolving cannabis market and driving the company's growth.
Track Record: Bradley J. Yourist's track record at Grapefruit USA, Inc. is still developing. His leadership has been focused on establishing the company's presence in the California cannabis market and promoting its Hourglass cream product. Evaluating his long-term impact will require monitoring the company's future financial performance and strategic initiatives.
GPFT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Grapefruit USA, Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited reporting requirements and may not be subject to the same level of scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier is generally associated with higher risk and greater potential for volatility compared to companies on more regulated exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Higher potential for volatility and price manipulation.
- Increased risk of fraud and scams.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Evaluate the company's capital structure and debt levels.
- Check for any pending lawsuits or regulatory actions.
- Consult with a financial advisor before investing.
- Company has a functioning website and online store.
- Company has a registered business address and contact information.
- Company has been in operation for several years.
- Company has a product available for sale (Hourglass cream).
- CEO is identified (Bradley J. Yourist).
Grapefruit USA, Inc. Stock: Key Questions Answered
What does Grapefruit USA, Inc. do?
Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products, primarily in California. The company focuses on developing and marketing cannabis-infused topical creams, with its flagship product being Hourglass, a time-release THC+CBD cream. These products are sold directly to consumers through the company's online store, targeting individuals seeking alternative wellness solutions within the legal cannabis market.
What do analysts say about GPFT stock?
As of March 17, 2026, there is no readily available analyst coverage or consensus on Grapefruit USA, Inc. (GPFT) due to its OTC listing and small market capitalization. Investors should conduct their own independent research and due diligence, considering the company's financial performance, growth prospects, and risk factors. The lack of analyst coverage highlights the speculative nature of this investment.
What are the main risks for GPFT?
Grapefruit USA, Inc. faces several key risks, including intense competition in the cannabis industry, evolving regulations and legal uncertainties, and fluctuations in cannabis prices and demand. The company's small size and limited financial resources also pose challenges. Additionally, its reliance on a single product (Hourglass cream) increases its vulnerability to market changes and consumer preferences. Investors should carefully consider these risks before investing in GPFT.
What are the key factors to evaluate for GPFT?
Grapefruit USA, Inc. (GPFT) currently holds an AI score of 45/100, indicating low score. Key strength: Focus on a specific niche (topical cannabis).. Primary risk to monitor: Potential: Intense competition from established players in the cannabis industry.. This is not financial advice.
How frequently does GPFT data refresh on this page?
GPFT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GPFT's recent stock price performance?
Recent price movement in Grapefruit USA, Inc. (GPFT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on a specific niche (topical cannabis).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GPFT overvalued or undervalued right now?
Determining whether Grapefruit USA, Inc. (GPFT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GPFT?
Before investing in Grapefruit USA, Inc. (GPFT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for Grapefruit USA, Inc.
- OTC market investments carry higher risk.